GlassScriptPhysician profile
Edward M Appelbaum
NPI 1356729602
$21,640.82
in general payments reported to CMS, 2019-2025
20 companies · $2,703 in 2025
The $2,703 reported for 2025 was more than what 75% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $49.31 · 2021: $10K · 2022: $3,158 · 2023: $2,080 · 2024: $3,570 · 2025: $2,703.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,771 · Food and Beverage: $2,582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,770.61 |
| Food and Beverage | $2,581.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $6,644.69 | 2020-2025 | |
| Kairos Surgical INC | $6,614.82 | 2021-2023 | |
| Eclipse Technology Solutions INC. | $4,042.73 | 2024-2025 | |
| Prodigy Surgical Distribution, INC. | $2,816.69 | 2021-2024 | |
| Stryker Corporation | $418.50 | 2021 | |
| Depuy Synthes Sales INC. | $215.12 | 2024 | Na, Tfn-Advance, Dynacord |
| Zimmer Biomet Holdings, INC. | $196.72 | 2024-2025 | Comprehensive Shoulder System, Sidus Stem-Free Shoulder |
| Smith+Nephew, INC. | $144.17 | 2025 | |
| Skeletal Dynamics INC | $114.85 | 2024 | Ijs, Implate, Geminus |
| Encore Medical, LP | $66.31 | 2024 | Djo Surgical |
| Collegium Pharmaceutical, INC. | $51.77 | 2024 | Xtampza, Belbuca |
| Bioventus LLC | $50.81 | 2021-2022 | |
| Vericel Corporation | $48.50 | 2024 | Maci |
| Medical Device Business Services, INC. | $47.16 | 2021 | |
| Davol INC. | $34.93 | 2024 | Arista Ah Flexitip |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.00 | 2024 | Relistor |
| Ferring Pharmaceuticals INC. | $31.02 | 2021 | |
| Liberty Surgical INC. | $27.55 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $21.13 | 2023 | Zilretta, Iovera, Exparel |
| Medtronic, INC. | $19.35 | 2024 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Appelbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.